As mentioned above we observed that higher baseline levels of SP-D result in a slightly enhanced risk of ARDS onset, while an increase in SP-D levels in the course of the disease lessens the risk of ARDS in patients with COVD-19. The gene discussed is SFTPD; the disease is acute respiratory distress syndrome.